We also explored possible changes in the expression of epidermal growth factor receptor (EGFR) and platelet‐derived growth factor receptor beta (PDGFRβ), since these receptors have previously been related to BRAFi resistance in melanomas (Vella et al., 2017; Wang et al., 2015). Here, EGFR is linked to melanoma.